The Vaccine Under the Microscope. Part 2: Graphene Fever

Actualizado: 21 feb


Read the first part of the interview if you haven't already, or review it before you read this one if you want to follow along.


As a result of the first part of this interview, which continues to grow, Juan Antonio Alija Esteban, a follower of La Quinta Columna (The Fifth Column)―with whom we have no relationship, but to whom we greatly appreciate the recognition on one of their live shows―contacted us. Remember, you can do the same anytime you like by sending us an email to the email address that appears on the website.

“In the hopes that part II will be carried out, I dare to propose a possible question to you. Have you observed graphene in any insulin? I have a daughter with diabetes who has not been vaccinated against COVID-19, but she does take two types of insulin daily. For the past few months, we have not been able to adequately control her blood glucose. I have read that diabetics are a group with many casualties due to COVID in the current "pandemic". Many of us are concerned about the possible existence of graphene in a medicine for daily use, and especially in high amounts. The work of a select few professionals, in various fields, who practice as such, is priceless. Hopefully, at some point, society will recognize your merits. Thanks a lot. All the best."

Answer: We have several vials of insulin of different kinds. We don't have the results yet. We can say that we have read the patent for an insulin that includes graphene in its composition. We will inform you as soon as we have the results and we will send you the patent so that you can check it. Keep in mind that it will not be a definitive indication until we have the images under the microscope.



"Once inside the cell, it produces the same effects as SARS-CoV-2 infection."

DFA: Based on your discoveries, what relevance do you think the vaccine has when it comes to fighting the virus?

BMI: I don't know. But, once undeclared content has been found in these vaccines, as a scientist, I am already skeptical of the rest of their components. So we would have to analyze the biological part of the vaccine to see if we find that messenger RNA that encodes the Spike protein. This is relatively easy to do with the right means. In truth, as much as the media affirms it, we don’t exactly know it is not known exactly what causes this disease. Right now, supposed infections are taking place in vaccinated people, but the symptoms coincide with the possible side effects of these vaccines, as stated in the scientific literature.

There are many in vitro studies that show the toxicity of this protein. Keep in mind that this protein binds to the same ACE2 receptor as SARS-CoV-2 and can trigger the same symptoms as the SARS-CoV-2 infection cycle. To further complicate matters, there is another fairly well-studied post-vaccination syndrome called Antibody-Dependent Immune Response (ADE). This occurs because when the virus mutates, as is supposedly happening now with the new strains, the antibodies produced by the previous vaccines are not specific for these new variants, and antigen-antibody sub-neutralizing units are formed, causing the virus to enter certain cells of our immune system, such as macrophages. Due to its non-specificity, the virus detaches from the antibody inside it and begins to replicate, producing the same symptoms as the infection of the virus itself, or even more severe. To date, we do not know if the symptoms we are observing correspond to the new strains of the virus or to secondary effects of these vaccines. This is what is being discussed on the subject today among expert scientists. As you can see, it is far from what we hear or read in the media. And to finish, complicating this even more if possible, the Acute Radiation Syndrome (ARS), supposedly produced by the interaction of graphene with Electromagnetic Radiation (EMR), also shares the same pathophysiological pathways.

DFA: Has any official analysis of the vaccine been published?

IMC: No. The Spanish Medicines Agency is supposed to carry out its quality controls as stated in its protocols, but the results of these controls have not been made public.

DFA: Could you describe the infection cycle of SARS-CoV-2?

IMC: This virus enters cells via the ACE2 receptor. All cells that express this receptor on their membrane are good candidates for infection with this virus. Once inside the cell, there is a direct cytotoxic effect that causes an imbalance in cell metabolism that can lead to cell death. The infection can also affect a very important enzyme system called Renin-Angiotensin. This complex body fluid regulation system is also dependent on the ACE2 receptor and is of great physiological and pathophysiological importance in the homeostasis of blood pressure, and water and sodium metabolism. When unbalanced, tissue damage, inflammation, vasoconstriction, and increased cell permeability can occur. If the infection progresses, a third effect occurs, which is endothelial damage and thromboinflammation, with a decrease in fibrinolysis and an increase in thrombin production. Finally, dysregulation of the immune system can occur, triggering hyperactive innate immunity with a cytokine storm. But this cycle of infection does not occur in the same way in all people. There are people with a cellular metabolism and an immune system that respond to viral infection before they trigger all or part of these pathophysiological imbalances. In these cases, the disease remains a common flu, or can evolve into what is commonly called severe COVID.

DFA: You mean that, as we already know, the virus and its different strains affect us differently. Which people can it hurt the most?

IMC: Those who have a more delicate state of health. Elderly people and those with comorbidities; immunosuppressed people, in general. Also people with autoimmune diseases. Keep in mind that the probability of the infection progressing to its most severe phase is greater with those who have a compromised immune system.

DFA: So it's bad enough on its own. What does the possible presence of graphene in the vaccines contribute?

IMC: Graphene, apart from being a blood clotting factor, also produces a direct cytotoxic effect that can trigger the same pathophysiological response that SARS-CoV-2 infection produces, and that I have just described.

DFA: The same pathophysiological response? There must be some difference.

IMC: The only difference is that graphene does not enter the cell via the ACE2 receptor, but rather by peroxidation of the lipid bilayer or by vacuolization, depending on the size and structure of these nanocomposites, whose family is very broad. Once inside the cell, they produce the same effects as SARS-CoV2 infection. There is a lot of scientific literature on the cytotoxicity of these compounds and that is the conclusion one would draw when it’s reviewed. But something else happens that must be taken into account: these nanocomposites interact with the electromagnetic field to which we are exposed, to a greater or lesser extent, via different sources. They do so by modulating and amplifying said field. Here is the problem—by amplifying said field, it puts it within the limit between ionizing and non-ionizing radiation. Let's say that the energy of said field depends on its frequency. Initially, the electromagnetic field of telephone antennas and such does not have enough energy to affect our health, but graphene increases its frequency by up to three orders of magnitude, from megahertz to terahertz. To understand me better, you have to look at the graph of the electromagnetic spectrum and see how it is arranged according to its frequency. If this were so, the interaction of the graphene introduced into the body with the electromagnetic field around us could produce a radiation syndrome in certain people.

DFA: What you are saying is quite terrifying.

IMC: At the moment it is just a hypothesis. It has not yet been verified on a strictly scientific level. However, although it may seem incredible, there is scientific literature linking SARS-CoV-2 infection with Acute Radiation Syndrome (ARS). These articles describe how the affectations at the pathophysiological level of both diseases coincide. In any case, the authors of these studies did not establish a cause-effect relationship between the two diseases. They pointed out their similarity to suggest the use of the same medicine that is used in radiation patients, since, as they themselves describe, they follow similar routes.

DFA: At this point, I think we laymen need to understand a few things. Let me take a step backwards in the interview. What is graphene? Where does it come from?

IMC: It is a substance composed of pure carbon, with atoms organized in a regular hexagonal pattern, similar to graphite. It was discovered in 2004 by two scientists of Russian origin: Andre Geim and Konstantin Novoselov. But the "graphene fever" began in 2010, the year in which these researchers received the Nobel Prize in Physics.

DFA: What was that "fever" about?

IMC: Graphene is a material that caused a lot of excitement after its discovery about fifteen years ago, due to its resistance and other qualities, which placed it in the future of many instruments and fields, from components to genetics.

IMC: Indeed, in countless areas: electronics, computing, mobile telephony, the energy sector, the armor industry, the automobile industry, the motor and fuel industry, the food industry, water treatment, the development of science and biosensors.

IMC: A biosensor is a device used to detect compounds through specific reactions. They are basically analytical devices that incorporate a biological and/or biomolecular material. A biosensor contains a bioreceptor that recognizes an analyte and converts its corresponding biological response into equivalent electrical, optical, or mechanical signals by means of a physical-chemical transducer or transduction microsystem that can be optical, electrochemical, or mechanical. In short, they are biocompatible artificial nanodevices with different uses in biomedicine.

DFA: For example?

IMC: Graphene is compatible with the delivery of drugs, cancer therapies, or biosensors, thanks to its large surface area, biocompatibility and chemical stability. Biosensors is another field open to this technology. Graphene has exceptional performance in detecting food toxins, environmental pollution, germs and specific bacteria. It can be applied, in turn, to DNA sequencing, which is crucial to the study of diseases of genetic origin, certain types of cancer and problems in the immune system. They can also be used for clinical diagnosis.

DFA: So, in the right hands, it could do us a lot of good, right?

BMI: Of course.

DFA: According to your theory, it doesn't seem to have fallen into good hands. What do you think they want?

IMC: We simply found microscopic structures after observations of anomalous phenomena related to vaccination. From there, it’s open to speculation. Personally, I think that there is some intention behind the attempt at worldwide vaccination using vaccines with patents with emergency-approved trade secrets that contain undeclared components, that do not immunize, that have multiple adverse side effects, and whose safety and efficacy studies are still ongoing, as indicated by the manufacturers themselves. It makes no sense to introduce an immunological passport with this type of vaccine when those vaccinated can also infect. It seems that things have backfired. So we are facing a perfect storm scenario where, until more research is done, it is very difficult to explain the origin of all of the symptoms that we are observing. The vaccine escape due to the new strains? The secondary effects of the vaccines due to the toxicity of the Spike protein or the ADE? The toxicity of graphene itself amplified by Electromagnetic Radiation and ARS? A mix of them? From a strictly scientific point of view, we still do not know.

DFA: Officials could easily nip such speculation in the bud. I wonder why they don't. We will continue next week...

IMC: That's what we all ask ourselves.

David F. Agredano

Translation: Kate Vredevoogd


228 visualizaciones0 comentarios

Entradas Recientes

Ver todo